Ziel
Through combining basic pre-clinical and clinical research, network analysis and computational modelling, RESOLVE aims at resolving the disturbed dynamics and mechanisms underlying the high triglyceride (HTG) and low high-density lipoprotein cholesterol (HDL-C) phenotype and insulin resistance in patients with metabolic syndrome (MetS) and its associated co-morbidities (cardiovascular disease, CVD; type 2 diabetes, T2DM; non-alcoholic fatty liver disease, NAFLD). RESOLVE will deliver on 6 specific objectives:
i) build a computational model for analyzing the kinetics of plasma lipids, lipoproteins and their interactions with glucose metabolism.
ii) apply the iterative systems biology cycle for calibrating, validating and improving the computational model in dedicated studies in mice
iii) build, calibrate and validate the computational model for use in humans.
iv) analyze – based on model and experimental data – which processes in the murine metabolic network regulate the physiological response to perturbations in lipid, lipoprotein and glucose metabolism and how these interact.
v) analyze – based on model and experimental data – which processes in the human metabolic network regulate the physiological response to perturbations in lipid, lipoprotein and glucose metabolism and how these interact
vi) use the human model to identify network-based drug targets aimed at restoring the metabolic dyslipidemia and glycemic control in patients with MetS and associated comorbidities.
RESOLVE 60-months project will result into a novel strategy for development of therapeutic strategies for MetS patients with T2DM, NAFLD or CVD.
Wissenschaftliches Gebiet
- medical and health sciencesclinical medicineendocrinologydiabetes
- natural sciencesbiological sciencesbiochemistrybiomoleculeslipids
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicinepathology
- medical and health sciencesclinical medicinehepatology
Programm/Programme
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2012-INNOVATION-1
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-IP - Large-scale integrating projectKoordinator
9713 GZ Groningen
Niederlande
Auf der Karte ansehen
Beteiligte (13)
Beteiligung beendet
69002 LYON
Auf der Karte ansehen
5612 AE Eindhoven
Auf der Karte ansehen
8006 ZURICH
Auf der Karte ansehen
59019 Lille
Auf der Karte ansehen
20251 Hamburg
Auf der Karte ansehen
70013 Irakleio
Auf der Karte ansehen
38302 Wolfenbuttel
Auf der Karte ansehen
20146 Hamburg
Auf der Karte ansehen
2650 Edegem
Auf der Karte ansehen
69002 LYON
Auf der Karte ansehen
1105AZ Amsterdam
Auf der Karte ansehen
405 30 Goeteborg
Auf der Karte ansehen
00014 Helsingin Yliopisto
Auf der Karte ansehen